Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of Clinical and Translational Neurology Année : 2021

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis

Jerome de Seze
  • Fonction : Auteur
Thibault Moreau
  • Fonction : Auteur
  • PersonId : 993356

Résumé

We compared Simoa and Ella immunoassays to assess serum neurofilament-light chain levels in 203 multiple sclerosis patients from the OFSEP HD study. There was a strong correlation (ρ = 0.86, p < 0.0001) between both platforms. The Ella instrument overestimated values by 17%, but as the data were linear (p = 0.57), it was possible to apply a correction factor to Ella results. As for Simoa , serum neurofilament-light chain levels measured by Ella were correlated with age and EDSS and were significantly higher in active multiple sclerosis, suggesting that these assays are equivalent and can be used in routine clinical practice.
Fichier principal
Vignette du fichier
Ann Clin Transl Neurol - 2021 - Gauthier - Comparison of SimoaTM and EllaTM to assess serum neurofilament%u2010light chain in.pdf (366.72 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03216866 , version 1 (31-05-2022)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Audrey Gauthier, Sébastien Viel, Magali Perret, Guillaume Brocard, Romain Casey, et al.. Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis. Annals of Clinical and Translational Neurology, 2021, 8 (5), pp.1141-1150. ⟨10.1002/acn3.51355⟩. ⟨hal-03216866⟩
186 Consultations
76 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More